Russel F G, Wouterse A C, van Ginneken C A
Department of Pharmacology, University of Nijmegen, The Netherlands.
J Pharmacol Exp Ther. 1989 Jan;248(1):436-46.
Plasma kinetics and renal excretion of 4-aminobenzoylglycine (p-aminohippurate), hydroxy- and methoxy-substituted benzoylglycines were studied in three Beagle dogs after rapid i.v. administration of about 1 g. Plasma protein binding of 4-amino-, 3-hydroxy- and 4-hydroxybenzoylglycine was low (less than 15%) and practically constant over a range of 5 to 450 micrograms/ml, whereas the 2-hydroxy analog showed concentration-dependent protein binding (40-80%). The excretory patterns of the 4-amino, 3- and 4-hydroxy analogs were essentially the same; rapid elimination from plasma into urine (greater than 80% of the dose), mainly by very efficient supply-limited tubular secretion. Conversely, the excretion of 2-hydroxybenzoylglycine was characterized by a lower plasma clearance and total renal excretion (64% of the dose), and a limited capacity of the tubular secretory system. The methoxybenzoylglycines showed nonlinear plasma protein binding varying between 10 and 70%, rapid clearance from plasma, largely by renal excretion (72-84% of the administered dose). Tubular secretion of 2- and 3-methoxybenzoylglycine was saturated, whereas complete saturation was not achieved for the 4-methoxy isomer. The kinetic parameters of tubular secretion were estimated with a physiologically based kidney model: 2-hydroxy, tubular transport maximum (TM) = 4.4 +/- 0.9 mg/min, Michael-Menten constant of the tubular secretion mechanism (KT) = 23 +/- 8 micrograms/ml; 2-methoxy-TM = 11.7 +/- 4.9 mg/min, KT = 42 +/- 9 micrograms/ml; 3-methoxy-TM = 8.8 +/- 1.0 mg/mn, KT = 27 +/- 20 micrograms/ml. Inasmuch as secretion of the other compounds was not saturated, only the intrinsic secretion clearance (CLint) = TM/KT could be estimated; 4-amino-CLint = 145 +/- 50 ml/min, 3-hydroxy-CLint = 194 +/- 21 ml/min, 4-hydroxy-CLint = 153 +/- 23 ml/min and 4-methoxy-CLint = 201 +/- 47 ml/min. The 4-methoxy isomer was metabolized to some extent by deconjugation of the glycine moiety and the resulting benzoate was found in plasma but not in urine.(ABSTRACT TRUNCATED AT 250 WORDS)
在三只比格犬中,快速静脉注射约1g后,研究了4-氨基苯甲酰甘氨酸(对氨基马尿酸)、羟基和甲氧基取代的苯甲酰甘氨酸的血浆动力学和肾排泄情况。4-氨基、3-羟基和4-羟基苯甲酰甘氨酸的血浆蛋白结合率较低(低于15%),在5至450微克/毫升范围内基本恒定,而2-羟基类似物表现出浓度依赖性蛋白结合(40-80%)。4-氨基、3-羟基和4-羟基类似物的排泄模式基本相同;从血浆快速排泄到尿液中(超过剂量的80%),主要通过非常有效的供应受限的肾小管分泌。相反,2-羟基苯甲酰甘氨酸的排泄特点是血浆清除率和总肾排泄率较低(剂量的64%),以及肾小管分泌系统的能力有限。甲氧基苯甲酰甘氨酸表现出非线性血浆蛋白结合,在10%至70%之间变化,从血浆中快速清除,主要通过肾排泄(给药剂量的72-84%)。2-和3-甲氧基苯甲酰甘氨酸的肾小管分泌饱和,而4-甲氧基异构体未完全饱和。用基于生理学的肾脏模型估计肾小管分泌的动力学参数:2-羟基,肾小管转运最大值(TM)=4.4±0.9毫克/分钟,肾小管分泌机制的米氏常数(KT)=23±8微克/毫升;2-甲氧基-TM=11.7±4.9毫克/分钟,KT=42±9微克/毫升;3-甲氧基-TM=8.8±1.0毫克/分钟,KT=27±20微克/毫升。由于其他化合物的分泌未饱和,只能估计内在分泌清除率(CLint)=TM/KT;4-氨基-CLint=145±50毫升/分钟,3-羟基-CLint=194±21毫升/分钟,4-羟基-CLint=153±23毫升/分钟,4-甲氧基-CLint=201±47毫升/分钟。4-甲氧基异构体在一定程度上通过甘氨酸部分的去结合代谢,血浆中发现了生成的苯甲酸盐,但尿液中未发现。(摘要截断于250字)